G2B BioSolutions Denmark ApS: Financial statements 2024
CVR: 43237748
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
G2B BioSolutions Denmark ApS (CVR 43237748) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -9,313 and a net result of DKK -9,563 compared with DKK -10,098 the year before. Equity in the 2024 report amounted to DKK 20,340. The solvency ratio was 100%.
- Gross Profit
- DKK -9,313
- Profit/Loss
- DKK -9,563
- Equity
- DKK 20,340
- Total Assets
- DKK 20,340
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -9 t. | -10 t. | 20 t. | 0 |
| 2023 | - | -10 t. | -10 t. | 30 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
G2B BioSolutions Denmark ApS has published its annual report for 2023. Gross profit came to DKK -10,098, and the net result was DKK -10,098.
About G2B BioSolutions Denmark ApS
G2B BioSolutions Denmark ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2022. The company has been dissolved. The company was registered under the industry Levering af kombinerede hjælpetjenester i forbindelse med drift af fast ejendom. According to the 2024 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK -9,313 and a net result of DKK -9,563 compared with DKK -10,098 the year before. Equity in the 2024 report amounted to DKK 20,340.